CCL4 and systemic sclerosis: CCL4 has been shown to act as a potent chemoattractant for monocytes and T cells [42], and serum levels and spontaneous production of CCL4 by peripheral blood mononuclear cells have been reported to be significantly elevated in patients with SSc [43–45].